We are live on
!
Find out more
Mawer Investment Management Portfolio holdings
AUM
$14.7B
1-Year Est. Return
12.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.9%
1 Year Est. Return
+12.5%
3 Year Est. Return
+48.6%
5 Year Est. Return
+72.73%
10 Year Est. Return
+305.03%
AUM
$19.5B
AUM Growth
+$812M
(+4.3%)
Cap. Flow
-$649M
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
46.76%
Holding
114
New
10
Increased
35
Reduced
59
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$58.1M |
| 2 |
Abbott
ABT
|
+$49.9M |
| 3 |
AbbVie
ABBV
|
+$43.3M |
| 4 |
Estee Lauder
EL
|
+$38M |
| 5 |
Robert Half
RHI
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$223M |
| 2 |
Kenvue
KVUE
|
+$138M |
| 3 |
Compañía de Cervecerías Unidas
CCU
|
+$62.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$59.2M |
| 5 |
CCF
Chase Corporation
CCF
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.39% |
| 2 | Technology | 21.03% |
| 3 | Industrials | 15.14% |
| 4 | Healthcare | 13.86% |
| 5 | Consumer Discretionary | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Dollar Tree
DLTR
$24.6B
| $2.16M | 0.01% |
+15,190
| New | +$1.8M |
|
102
Copart
CPRT
$27.2B
| $1.84M | 0.01% |
37,628
+3,104
| +9% | +$147K |
|
103
VeriSign
VRSN
$26B
| $1.78M | 0.01% |
8,662
+710
| +9% | +$148K |
|
104
iShares MSCI France ETF
EWQ
$334M
| $1.17M | 0.01% |
+29,828
| New | +$1.09M |
|
105
Apple
AAPL
$4.45T
| $543K | ﹤0.01% |
2,820
| – | – |
|
106
Berkshire Hathaway Class B
BRK.B
$1.11T
| $267K | ﹤0.01% |
750
| – | – |
|
|
107
Kenvue
KVUE
$36.6B
| $237K | ﹤0.01% |
10,988
-6,898,214
| -100% | -$138M |
|
108
Cellebrite
CLBT
$4B
| – | – |
-323,310
| Closed | -$2.47M |
|
109
Elastic
ESTC
$7.94B
| – | – |
-22,607
| Closed | -$1.84M |
|
110
Infosys
INFY
$51B
| – | – |
-273,173
| Closed | -$4.67M |
|
|
NVEE
111
DELISTED
NV5 Global
NVEE
| – | – |
-60,996
| Closed | -$1.47M |
|
|
112
Organon & Co
OGN
$3.58B
| – | – |
-12,847,934
| Closed | -$223M |
|
113
XPEL
XPEL
$1.32B
| – | – |
-43,419
| Closed | -$3.35M |
|
|
CCF
114
DELISTED
Chase Corporation
CCF
| – | – |
-423,200
| Closed | -$53.8M |
|
Similar funds
BGC
GF
JFG
AT
IA
IFP
SSA
FGP
Mawer Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Mawer Investment Management held 114 positions worth $19.5B, up 4.3% from $18.7B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Mawer Investment Management withdrew a net $649M in Q4 2023, closing 7 positions and reducing 59 holdings. Its most notable exit was Organon & Co, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.
Against the trend, Mawer Investment Management opened a new position in AbbVie worth $46.1M.
- Mawer Investment Management's largest Q4 2023 buy was AbbVie: 297,227 shares worth $46.1M.
- Mawer Investment Management added most to Shell in Q4 2023, an estimated $58.1M increase.
- Mawer Investment Management's biggest Q4 2023 reduction was Kenvue, cutting an estimated $138M.
- Mawer Investment Management fully exited Organon & Co in Q4 2023, selling an estimated $223M.
- Mawer Investment Management's ten largest holdings make up 47% of its $19.5B portfolio in Q4 2023.
- Mawer Investment Management opened 10 new positions and closed 7 in Q4 2023.
- Mawer Investment Management's portfolio value rose 4.3% quarter-over-quarter to $19.5B.
Based on Mawer Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.